Clinical Trial Update: A Study to Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pharmacokinetic interactions among Simeprevir, Ledipasvir, and Sofosbuvir in treatment-naive chronic hepatitis C genotype 1 patients; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir (ledipasvir)
• Simeprevir (simeprevir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Janssen Sciences Ireland UC | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2017-01-05